Recently closed $50 million underwritten offering reinforces strong institutional investor conviction and bolsters balance sheet for execution of second Phase 3 HLP003 trial1- 2,3, EMBRACE, for potent ...

Advances strategic shift toward a disciplined research model prioritizing external innovation to accelerate rare disease pipeline growth- ...

Five day camp begins June 29 and will end with a 3-on-3 tournament on July 3.

[6] All States Would Face Significant Increased Costs, Many Would Owe Far More Since SNAP’s start in its current form nearly 50 years ago, the federal government has fully funded the cost of SNAP food ...

Provides broad overview of Company's research and early development programs expected to continue to fuel future ...

Explore the evolving landscape of male contraception, including novel nonhormonal pills and injectable hydrogels in clinical ...

The City of Everett is launching a new gallery of pre-approved accessory dwelling units (ADU), making it faster, simpler and more affordable for homeowners to ...

A lot of Nigerian organisations are doing real, meaningful work. Community development groups running free skill acquisition programs. Faith-based ...

AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...

PARP inhibitors reshaped oncology when they first reached patients some 10 years ago, but they represent just one entry point into a much larger and more intricate biological network.

Practice and feedback work in tandem in good PD design. But the starting point is just as important, said Schroeder. While ...

(Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver metastases, ...